Innovative Medicines Initiative

Innovative Medicines Initiative Joint Technology Initiative [JTI]

The Innovative Medicines Initiative JTI is a Public-Private Partnership (PPP) between the pharmaceutical industry represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Communities represented by the European Commission.  With the overall goal to make Europe the world leader in pharmaceutical research for the benefit of the economy and society, by removing research bottlenecks in the current drug development process.

Innovative Medicines Initiative JTI is a high scale pan-European collaboration between the European Community and the bio-pharmaceutical industry.   The Innovative Medicines Initiative JTI Joint Undertaking Research Agenda is based on the recommendations of the Strategic Research Agenda that was developed by the European Technology Platform on Innovative Medicines through extensive consultation with a large group of stakeholders from academia, SMEs, regulatory agencies and patient organisations.

To find out more contact
Graham M Mobbs
European Operations Manager
Technology Strategy Board
graham.mobbs@tsb.gov.uk

 

Last updated on Wednesday 21 November 2012 at 11:33

Copyright © 2013